How to Get Your Employer to Cover GLP-1 Weight Loss Medications

The short answer is cost, and the structural reason it's even possible for employers to make this call at all comes down to how their health plan is set up. Large companies with self-funded (self-insured) plans — which cover the majority of workers at big U.S. employers — pay employee claims directly out of company funds, using an insurance carrier only to administer the plan. That means the employer, not a state insurance regulator, decides what's covered, largely exempt from state benefit mandates under federal ERISA law. With GLP-1 list prices commonly running well over $1,000 a month and a meaningful share of any workforce potentially eligible under broad weight-based criteria, some employers have excluded weight-loss use entirely or added strict prior authorization to control costs — even as they continue covering the same drugs for type 2 diabetes. A 2024 KFF Employer Health Benefits Survey found that only about a quarter of large firms covered GLP-1s specifically for weight loss, a figure that's grown since but still leaves most employees without automatic coverage. Some employers have gone the other direction too — a handful of well-publicized cases, including certain state employee health plans, dropped weight-loss GLP-1 coverage entirely in 2024 after costs outpaced projections, showing this is an actively shifting landscape rather than a settled policy.

Start with your plan's Summary of Benefits and Coverage (SBC) or Summary Plan Description, available through your HR portal or benefits administrator — search specifically for 'weight management,' 'anti-obesity medication,' or the drug names themselves, since exclusions are often written narrowly. If the language is unclear, call the number on your insurance card and ask directly: 'Is semaglutide or tirzepatide covered for a weight-loss diagnosis, and what's the prior authorization criteria?' This is different from asking whether it's covered for diabetes, since many plans cover the same drug differently depending on the diagnosis code attached to the prescription. It's also worth asking your HR benefits contact whether your plan is self-funded or fully insured, since that tells you whether the decision sits with your employer directly (self-funded) or is shaped by state insurance rules and the carrier's standard offerings (fully insured) — which changes who you'd actually need to influence to get a policy changed. Understanding [how GLP-1 insurance coverage generally works](/blog/does-insurance-cover-glp1-for-weight-loss-2026) before this call will help you ask sharper questions.

Individual requests to HR rarely move the needle on their own, since a single employee's ask doesn't change an employer's cost-benefit calculation. What tends to work better is routing the request through a benefits committee if your company has one, or working with your HR benefits lead to raise it as part of the annual renewal and open enrollment cycle, typically several months before the new plan year — this is when employers are actively reviewing plan design with their broker and insurance carrier, and changes are realistically possible. Bringing data helps: employers increasingly weigh the cost of covering GLP-1s against downstream savings on diabetes complications, cardiovascular events, and disability claims, so framing the ask around total cost of care rather than just 'please cover this' tends to land better with benefits decision-makers who think in those terms. If your company works with a benefits broker or consultant (common at mid-size and larger employers), asking HR whether that broker has modeled GLP-1 coverage options is a reasonable and non-confrontational way to get the conversation started.

Often, yes. Many plans that exclude coverage 'for weight loss' still cover the exact same medications for type 2 diabetes, and some extend coverage to obstructive sleep apnea or specific cardiovascular risk categories, especially following trial data like the SELECT and SURMOUNT-OSA studies that expanded FDA-approved indications beyond weight loss alone. If you have a diagnosed comorbidity, ask your prescriber to document it clearly and submit the prior authorization under that diagnosis rather than a general weight-loss code — this single step resolves more denials than any appeal letter. If a claim is denied anyway, it's worth understanding [how to appeal a GLP-1 insurance denial](/blog/glp1-insurance-denial-how-to-appeal-prior-authorization-2026) before giving up, since a meaningful share of initial denials are overturned on appeal once additional clinical documentation is provided.

Collective requests carry more weight than individual ones, largely because they signal to an employer that this isn't a one-off ask but a pattern affecting retention and satisfaction across the workforce. Employee resource groups focused on health, wellness, or working parents have successfully raised benefits requests at some companies by collecting anonymized interest data (how many employees would use this benefit) and presenting it to HR as a single organized ask rather than scattered individual emails. At unionized workplaces, prescription drug coverage — including specific drug classes — is a legitimate subject for collective bargaining, and it's worth raising with union leadership ahead of a contract renewal cycle rather than waiting for an individual grievance process that isn't designed to change plan-wide coverage.

If a policy change genuinely isn't happening this cycle, several fallback paths remain. Manufacturer [savings cards](/blog/glp1-savings-cards-2026-complete-guide) can significantly reduce out-of-pocket cost for commercially insured patients even without a specific weight-loss benefit, though eligibility rules vary and change periodically. If you have access to an [FSA or HSA](/blog/fsa-hsa-for-glp1-what-is-eligible-2026), GLP-1 medications prescribed for a diagnosed medical condition are generally an eligible expense, which effectively gives you a pre-tax discount regardless of your insurance's specific weight-loss policy. Telehealth-based prescribing services and, for eligible patients, [Medicare and Medicaid coverage pathways](/blog/medicare-medicaid-glp1-coverage-2026-what-is-covered) (if applicable to your situation) are worth exploring too. None of these fully replace comprehensive employer coverage, but layering them can meaningfully close the gap while you continue advocating for a plan change at the next renewal.

Every employer's plan is different, and figuring out the fastest path to coverage — or the best combination of savings tools if coverage isn't happening soon — depends on details specific to your plan and diagnosis. If you want help thinking through your options or preparing what to say to HR or your prescriber, that's a good place to start.